Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services tags : Biopharma save search
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
business year update biopharma financial results
Sunshine Biopharma Announces Reverse Stock Split
Published: 2024-04-12 (Crawled : 17:00) - biospace.com/
SBFM | $3.32 -12.63% -20.25% 2.7M
|
Professional, Scientific, and T...
|
| O: -2.41%
H: 0.0%
C: -5.76%
biopharma
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
SBFM | $3.32 -12.63% -20.25% 2.7M
|
Professional, Scientific, and T...
|
| O: 83.97%
H: 18.6%
C: -4.31%
year biopharma results
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
Published: 2024-03-19 (Crawled : 13:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: 2.42%
H: 0.0%
C: -5.51%
conference disease biopharma
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
Published: 2024-03-07 (Crawled : 22:00) - globenewswire.com
PYXS | $4.53 -6.21% -7.1% 470K
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 1.13%
C: -9.19%
conference biopharma global
Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
Published: 2024-03-06 (Crawled : 13:30) - werewolftx.com
HOWL | $5.87 0.51% 0.51% 120K
|
Professional, Scientific, and T...
|
| O: 2.05%
H: 2.87%
C: 0.86%
conference biopharma global therapeutics
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
CMPX | $1.49 -2.61% -2.0% 170K
|
Professional, Scientific, and T...
|
| O: 5.17%
H: 1.09%
C: -2.73%
conference biopharma global therapeutics
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
Published: 2024-02-12 (Crawled : 22:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: -1.18%
H: 5.56%
C: -2.78%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
biopharma
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
Published: 2023-12-12 (Crawled : 11:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: -8.59%
H: 5.75%
C: -0.57%
positive biopharma global topline results
Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023
Published: 2023-12-11 (Crawled : 21:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: -8.59%
H: 5.75%
C: -0.57%
biopharma global trial
Sunshine Biopharma Moves Principal Office to New York City
Published: 2023-12-04 (Crawled : 13:30) - globenewswire.com
SBFM | $3.32 -12.63% -20.25% 2.7M
|
Professional, Scientific, and T...
|
| O: -3.45%
H: 3.54%
C: -4.29%
biopharma city
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
Published: 2023-11-21 (Crawled : 11:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: 6.31%
H: 2.28%
C: -42.47%
biopharma collaboration agreement china
Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis
Published: 2023-11-21 (Crawled : 11:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: 6.31%
H: 2.28%
C: -42.47%
dermatitis positive biopharma trial china
Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023
Published: 2023-11-20 (Crawled : 22:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: 6.31%
H: 2.28%
C: -42.47%
dermatitis biopharma trial china
Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition
Published: 2023-11-13 (Crawled : 14:30) - biospace.com/
SBFM | $3.32 -12.63% -20.25% 2.7M
|
Professional, Scientific, and T...
|
| O: 0.38%
H: 3.45%
C: -12.41%
year biopharma acquisition
Acumen Pharmaceuticals to Participate in the UBS Biopharma Conference
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
ABOS | $3.16 -8.93% -9.12% 640K
|
Professional, Scientific, and T...
|
| O: 3.34%
H: 0.0%
C: 0.0%
conference biopharma pharmaceuticals
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
Published: 2023-09-12 (Crawled : 20:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: -1.02%
H: 4.0%
C: 3.99%
business update biopharma financial results
Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
Published: 2023-09-12 (Crawled : 10:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: -1.41%
H: 0.0%
C: -1.43%
nasdaq biopharma
Connect Biopharma to Participate in Upcoming September Investor Conferences
Published: 2023-08-24 (Crawled : 22:00) - globenewswire.com
CNTB | $1.52 -1.93% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.65%
C: 0.0%
biopharma
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
Published: 2023-08-11 (Crawled : 12:20) - globenewswire.com
SBFM | $3.32 -12.63% -20.25% 2.7M
|
Professional, Scientific, and T...
|
| O: 15.33%
H: 7.55%
C: -13.29%
biopharma
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.